Nurix Therapeutics chief legal officer Christine Ring reports sale of 16,715 shares
NRIX•Christine Ring sold 16,715 Nurix Therapeutics shares on Nov. 2-3, 2026, and exercised options for 5,786 shares at $8.72 each; her direct holdings stood at 4,406 shares afterward.
